CureVac

Last updated: October 09, 2024

Ingmar Hoerr, CEO
Ingmar Hoerr, CEO
Germany | Funding: $2.1B (+)

Website: http://www.curevac.com/

CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.